[1] Vahey MD, Fletcher DA. Low-fidelity assembly of influenza a virus promotes escape from host cells. Cell 2020;180(1):205. https://doi.org/10.1016/j.cell.2019.12.028.
[2] Stadlbauer D, Zhu XY, McMahon M, Turner JS, Wohlbold TJ, Schmitz AJ, et al. Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science 2019;366(6464):499 − 504. https://doi.org/10.1126/science.aay0678.
[3] Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol 2021;93(8):4638 − 46. https://doi.org/10.1002/jmv.26990.
[4] Cowling BJ, Ip DKM, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun 2013;4(1):1935. https://doi.org/10.1038/ncomms2922.
[5] Nittayananta W, Lerdsamran H, Chutiwitoonchai N, Promsong A, Srichana T, Netsomboon K, et al. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity. Virol J 2024;21(1):26. https://doi.org/10.1186/s12985-023-02282-x.
[6] Kim DK, Poudel B. Tools to detect influenza virus. Yonsei Med J 2013;54(3):560 − 6. https://doi.org/10.3349/ymj.2013.54.3.560.
[7] Srivastava P, Prasad D. Isothermal nucleic acid amplification and its uses in modern diagnostic technologies. 3 Biotech 2023;13(6):200. https://doi.org/10.1007/s13205-023-03628-6.
[8] Zhou J, Ren XM, Wang X, Li Z, Xian CJ. Recent advances and challenges of the use of the CRISPR/Cas system as a non-nucleic acid molecular diagnostic. Heliyon 2023;9(12):e22767. https://doi.org/10.1016/j.heliyon.2023.e22767.
[9] Hillary VE, Ceasar SA. A review on the mechanism and applications of CRISPR/Cas9/Cas12/Cas13/Cas14 proteins utilized for genome engineering. Mol Biotechnol 2023;65(3):311 − 25. https://doi.org/10.1007/s12033-022-00567-0.
[10] Vivaldi G, Pfeffer PE, Talaei M, Basera TJ, Shaheen SO, Martineau AR. Long-term symptom profiles after COVID-19vsother acute respiratory infections: an analysis of data from the COVIDENCE UK study. eClinicalMedicine 2023;65:102251. https://doi.org/10.1016/j.eclinm.2023.102251.
[11] Su PP, Jiang CS, Zhang YM. The implication of infection with respiratory syncytial virus in pediatric recurrent wheezing and asthma: knowledge expanded post-COVID-19 era. Eur J Clin Microbiol Infect Dis 2024;43(3):403 − 16. https://doi.org/10.1007/s10096-023-04744-0.
[12] Kong HM, Yi K, Mintz RL, Wang B, Xu YT, Lao YH, et al. CRISPR/Cas detection with nanodevices: moving deeper into liquid biopsy. Chem Commun (Camb) 2024;60(17):2301 − 19. https://doi.org/10.1039/d3cc05375j.
[13] Asmamaw Mengstie M, Teshome Azezew M, Asmamaw Dejenie T, Teshome AA, Tadele Admasu F, Behaile Teklemariam A, et al. Recent advancements in reducing the off-target effect of CRISPR-Cas9 genome editing. Biologics 2024;18:21 − 8. https://doi.org/10.2147/BTT.S429411.
[14] Watters KE, Fellmann C, Bai HB, Ren SM, Doudna JA. Systematic discovery of natural CRISPR-Cas12a inhibitors. Science 2018;362(6411):236 − 9. https://doi.org/10.1126/science.aau5138.
[15] Li J, Zhang K, Lin GG, Li JM. CRISPR-Cas system: a promising tool for rapid detection of SARS-CoV-2 variants. J Med Virol 2024;96(1):e29356. https://doi.org/10.1002/jmv.29356.
[16] Zhao F, Hu YM, Fan ZL, Huang BY, Wei L, Xie Y, et al. Rapid and sensitive one-tube detection of mpox virus using RPA-coupled CRISPR-Cas12 assay. Cell Rep Methods 2023;3(10):100620. https://doi.org/10.1016/j.crmeth.2023.100620.
[17] Zeng RJ, Gong HX, Li YL, Li YX, Lin W, Tang DP, et al. CRISPR-Cas12a-derived photoelectrochemical biosensor for point-of-care diagnosis of nucleic acid. Anal Chem 2022;94(20):7442 − 8. https://doi.org/10.1021/acs.analchem.2c01373.
[18] Wei LY, Wang ZL, Wu L, Chen YP. CRISPR/Cas12a-based magnetic relaxation switching biosensor for nucleic acid amplification-free and ultrasensitive detection of methicillin-resistantStaphylococcus aureus. Biosens Bioelectron 2023;222:114984. https://doi.org/10.1016/j.bios.2022.114984.
[19] Zhang FY, Shang JJ, Luo J, Yin XH, Yu XM, Jiang W, et al. Development of a recombinase-aided amplification combined with a lateral flow dipstick assay for rapid detection of H7 subtype avian influenza virus. Front Microbiol 2023;14:1286713. https://doi.org/10.3389/fmicb.2023.1286713.
[20] Jiang T, Li G, Liu RD, Zhou J, Gao NN, Shen JL. Creating an ultra-sensitive detection platform for monkeypox virus DNA based on CRISPR technology. J Med Virol 2023;95(7):e28905. https://doi.org/10.1002/jmv.28905.
[21] Shen PJ, Si ZJ, Huang D, Xu ZP, Wang ZY, Fang MJ, et al. CRISPR Cas12a-enabled biosensors coupled with commercial pregnancy test strips for the visible point-of-care testing of SARS-CoV-2. Analyst 2023;148(11):2573 − 81. https://doi.org/10.1039/D3AN00284E.
[22] Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013;339(6121):819 − 23. https://doi.org/10.1126/science.1231143.
[23] Yin XY, Yang LL, Sun XY, Zheng QY, Piao Y, Hu B, et al. Development and validation of sensitive and rapid CRISPR/Cas12-based PCR method to detect hazelnut in unlabeled products. Food Chem 2024;438:137952. https://doi.org/10.1016/j.foodchem.2023.137952.
[24] Zhou X, Wang SW, Ma Y, Li YB, Deng GH, Shi JZ, et al. Rapid detection of avian influenza virus based on CRISPR-Cas12a. Virol J 2023;20(1):261. https://doi.org/10.1186/s12985-023-02232-7.
Baidu
map